550 related articles for article (PubMed ID: 34633681)
1. Diagnostic, therapeutic, and prognostic implications of the 2021 World Health Organization classification of tumors of the central nervous system.
Gritsch S; Batchelor TT; Gonzalez Castro LN
Cancer; 2022 Jan; 128(1):47-58. PubMed ID: 34633681
[TBL] [Abstract][Full Text] [Related]
2. World Health Organization 2021 Classification of Central Nervous System Tumors and Implications for Therapy for Adult-Type Gliomas: A Review.
Berger TR; Wen PY; Lang-Orsini M; Chukwueke UN
JAMA Oncol; 2022 Oct; 8(10):1493-1501. PubMed ID: 36006639
[TBL] [Abstract][Full Text] [Related]
3. Major Changes in 2021 World Health Organization Classification of Central Nervous System Tumors.
Kurokawa R; Kurokawa M; Baba A; Ota Y; Pinarbasi E; Camelo-Piragua S; Capizzano AA; Liao E; Srinivasan A; Moritani T
Radiographics; 2022; 42(5):1474-1493. PubMed ID: 35802502
[TBL] [Abstract][Full Text] [Related]
4. 2021 updates to the World Health Organization classification of adult-type and pediatric-type diffuse gliomas: a clinical practice review.
Thomas DL
Chin Clin Oncol; 2023 Feb; 12(1):7. PubMed ID: 36922356
[TBL] [Abstract][Full Text] [Related]
5. Beyond the World Health Organization classification of central nervous system tumors 2016: what are the new developments for gliomas from a clinician's perspective?
Weller M; Reifenberger G
Curr Opin Neurol; 2020 Dec; 33(6):701-706. PubMed ID: 33177376
[TBL] [Abstract][Full Text] [Related]
6. Classification of adult-type diffuse gliomas: Impact of the World Health Organization 2021 update.
Whitfield BT; Huse JT
Brain Pathol; 2022 Jul; 32(4):e13062. PubMed ID: 35289001
[TBL] [Abstract][Full Text] [Related]
7. Novel insight into histological and molecular astrocytoma, IDH-mutant, Grade 4 by the updated WHO classification of central nervous system tumors.
Chen W; Guo S; Wang Y; Shi Y; Guo X; Liu D; Li Y; Wang Y; Xing H; Xia Y; Li J; Wu J; Liang T; Wang H; Liu Q; Jin S; Qu T; Li H; Yang T; Zhang K; Wang Y; Ma W
Cancer Med; 2023 Sep; 12(18):18666-18678. PubMed ID: 37667984
[TBL] [Abstract][Full Text] [Related]
8. Updates on the WHO diagnosis of IDH-mutant glioma.
Reuss DE
J Neurooncol; 2023 May; 162(3):461-469. PubMed ID: 36717507
[TBL] [Abstract][Full Text] [Related]
9. Classification and Grading of Central Nervous System Tumors According to the World Health Organization 5th Edition.
Yoda RA; Cimino PJ
Semin Neurol; 2023 Dec; 43(6):833-844. PubMed ID: 37949117
[TBL] [Abstract][Full Text] [Related]
10. Adult type diffuse gliomas in the new 2021 WHO Classification.
Antonelli M; Poliani PL
Pathologica; 2022 Dec; 114(6):397-409. PubMed ID: 36534419
[TBL] [Abstract][Full Text] [Related]
11. Reclassification of TCGA Diffuse Glioma Profiles Linked to Transcriptomic, Epigenetic, Genomic and Clinical Data, According to the 2021 WHO CNS Tumor Classification.
Zakharova G; Efimov V; Raevskiy M; Rumiantsev P; Gudkov A; Belogurova-Ovchinnikova O; Sorokin M; Buzdin A
Int J Mol Sci; 2022 Dec; 24(1):. PubMed ID: 36613601
[TBL] [Abstract][Full Text] [Related]
12. Changes to pediatric brain tumors in 2021 World Health Organization classification of tumors of the central nervous system.
Oztek MA; Noda SM; Romberg EK; Cole BL; Wright JN; Ishak GE; Perez FA
Pediatr Radiol; 2023 Mar; 53(3):523-543. PubMed ID: 36348014
[TBL] [Abstract][Full Text] [Related]
13. [World Health Organization Classification of Central Nervous System Tumours, 5
Ichimura K
No Shinkei Geka; 2023 Mar; 51(2):349-363. PubMed ID: 37055056
[TBL] [Abstract][Full Text] [Related]
14. The World Health Organization Classification of Tumors of the Central Nervous System, Fifth Edition, 2021: A Critical Analysis.
Miller DC
Adv Tech Stand Neurosurg; 2023; 46():1-21. PubMed ID: 37318567
[TBL] [Abstract][Full Text] [Related]
15. Central nervous system.
Adamson DC; Rasheed BA; McLendon RE; Bigner DD
Cancer Biomark; 2010; 9(1-6):193-210. PubMed ID: 22112477
[TBL] [Abstract][Full Text] [Related]
16. Applications of molecular neuro-oncology - a review of diffuse glioma integrated diagnosis and emerging molecular entities.
Wood MD; Halfpenny AM; Moore SR
Diagn Pathol; 2019 Apr; 14(1):29. PubMed ID: 30967140
[TBL] [Abstract][Full Text] [Related]
17. The Evolving Classification of Diffuse Gliomas: World Health Organization Updates for 2021.
Perez A; Huse JT
Curr Neurol Neurosci Rep; 2021 Nov; 21(12):67. PubMed ID: 34817712
[TBL] [Abstract][Full Text] [Related]
18. The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary.
Louis DN; Perry A; Reifenberger G; von Deimling A; Figarella-Branger D; Cavenee WK; Ohgaki H; Wiestler OD; Kleihues P; Ellison DW
Acta Neuropathol; 2016 Jun; 131(6):803-20. PubMed ID: 27157931
[TBL] [Abstract][Full Text] [Related]
19. Opinion & Special Article: Glioma Classification: How to Interpret Molecular Markers in a Diffuse Glioma Pathology Report.
van der Meulen M; Ramos RC; Mason WP; Von Deimling A; Maas SLN
Neurology; 2022 Nov; 99(20):903-908. PubMed ID: 36240081
[TBL] [Abstract][Full Text] [Related]
20. 2021 World Health Organization Classification of Brain Tumors.
Meredith DM; Pisapia DJ
Continuum (Minneap Minn); 2023 Dec; 29(6):1638-1661. PubMed ID: 38085892
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
